Market Place
Sourcing Support
Obsidian Therapeutics to Present Clinical Data on OBX-115 at 2025
23 Apr 2025 //
BUSINESSWIRE
Obsidian Therapeutics to Present at 43rd J.P. Morgan Conference
06 Jan 2025 //
BUSINESSWIRE
Obsidian to Present OBX-115 & cytoDRiVE® Data at SITC 2024
05 Nov 2024 //
BUSINESSWIRE
Obsidian`s OBX-115 Safety, Efficacy Data In ASCO Oral Presentation
03 Jun 2024 //
BUSINESSWIRE
Obsidian Obx-115 Melanoma Positive: Advanced Patient Data Asco 2024
23 May 2024 //
BUSINESSWIRE
Obsidian Therapeutics Appoints Dana Alexander as Chief Technical Officer
08 May 2024 //
BUSINESSWIRE
Obsidian Appoints Jeffrey Trigilio As CFO
15 Apr 2024 //
BUSINESSWIRE
Obsidian Therapeutics Shares Study Data on OBX-115
09 Apr 2024 //
BUSINESSWIRE
Obsidian Therapeutics rakes in $160M for solid tumor cell therapy program
03 Apr 2024 //
ENDPTS
Obsidian Therapeutics Announces Clinical & Preclinical Presentations
05 Mar 2024 //
BUSINESSWIRE
Obsidian Announces Positive Interim Top-Line Clinical Data for OBX-115
12 Dec 2023 //
BUSINESSWIRE
Obsidian Therapeutics Announces Dr. Madan Jagasia as Chief Executive Officer
23 May 2023 //
BUSINESSWIRE
Maria Fardis ends a two-year CEO hiatus; More leadership turnover at Galapagos
05 May 2023 //
ENDPTS
Bristol Myers inks extension to Obsidian cell therapy pact
27 Oct 2022 //
FIERCEBIOTECH
Obsidian Therapeutics to Present Preclinical Data from cytoTIL15 Program at AACR
11 Apr 2022 //
PRNEWSWIRE
Software for the DNA hardware: Chroma snags $125M for epigenome
18 Nov 2021 //
FIERCEBIOTECH
Obsidian to Present In Vivo Anti-Tumor Efficacy Data from Novel cytoTIL15
09 Nov 2021 //
YAHOOFINANCE
Obsidian To Present Preclinical Data From cytoTIL15 Program at ESMO 2021
15 Sep 2021 //
PRNEWSWIRE
Obsidian Therapeutics Closes $115M Series B Financing
09 Sep 2021 //
FINSMES
A new clutch of biotech blue-chippers joins Obsidian to craft next-gen drugs
09 Sep 2021 //
ENDPTS
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.